46-60 of 282
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiersReviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiersBeyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Ashley Baker, MSN, PMHNP
Suzanne E. Schindler, MD, PhD
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
NeuroFrontiersThe BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
ECTRIMS 2024 Updates: How Menopause Impacts Women with MS
NeuroFrontiersECTRIMS 2024 Updates: How Menopause Impacts Women with MS
Riley Bove, MD, MMSc
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
NeuroFrontiersResearching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Charles Turck, PharmD, BCPS, BCCCP
Jasmohan Bajaj, MD
Managing Osteoporosis: How to Create Personalized Treatment Plans
Living RheumManaging Osteoporosis: How to Create Personalized Treatment Plans
Michael Lewiecki, MD, FACP, FACE
- advertisement
Concepts in Osteoporosis Care: Coverage, Sequencing, and Comparative Effectiveness
Living RheumConcepts in Osteoporosis Care: Coverage, Sequencing, and Comparative Effectiveness
Michael Lewiecki, MD, FACP, FACE
ADHD in Older Adults: Key Diagnostic and Treatment Strategies
NeuroFrontiersADHD in Older Adults: Key Diagnostic and Treatment Strategies
Ashley Baker, MSN, PMHNP
David Goodman, MD, LFAPA
Active Aging: Preventing Heart Failure in Older Women with Exercise
Heart MattersActive Aging: Preventing Heart Failure in Older Women with Exercise
Javed Butler, MD
Michael J. LaMonte, PhD, MPH
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
NeuroFrontiersHow Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
Charles Turck, PharmD, BCPS, BCCCP
Jagan Pillai, MD, PhD
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiersToxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Andrew Wilner, MD, FACP, FAAN
Marcus E. Peter, PhD
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
NeuroFrontiersExamining the Role of Toxic Tau Proteins in Alzheimer's Disease
Andrew Wilner, MD, FACP, FAAN
George Bloom, PhD
- advertisement
PBA Treatment May Reverse Signs of Alzheimer’s Disease
NeuroFrontiersPBA Treatment May Reverse Signs of Alzheimer’s Disease
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Jini Naidoo, PhD
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
NeuroFrontiersAlzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Andrew Wilner, MD, FACP, FAAN
Marc Haut, PhD
Could Excessive Sleeping Indicate Cognitive Decline in Older Adults?
What Your Patients Are Talking AboutCould Excessive Sleeping Indicate Cognitive Decline in Older Adults?
Brian P. McDonough, MD, FAAFP
